Page 164 - JSOM Summer 2022
P. 164

3.  The meloxicam and acetaminophen contained in the   Option 3
              CoTCCC-recommended Combat Wound Medication Pack     •  Moderate to Severe Pain
            provides moderate analgesia and avoids adverse effects, and   •  Casualty IS in hemorrhagic shock or respiratory dis-
            will be more easily supported logistically with the 1000mg   tress OR
            dose of acetaminophen. Acetaminophen is more widely   •  Casualty IS at significant risk of developing either
            available as 500mg tabs in the military medical logisti-  condition
            cal system in comparison to the previously recommended     o Ketamine 50mg IM or IN
            1300mg dose, which was based on two 650mg tabs. This   OR
            should be used for casualties whose pain is not severe and     o Ketamine 20mg slow IV or IO
            who are still able to be effective combatants.             ■   Repeat doses q30min PRN for IM or IN
          4.  Ketamine provides excellent analgesia, particularly at the   ■   Repeat doses q20min PRN for IV or IO
            increased dose of 30mg. This agent minimizes the risk of   ■   End points: Control of pain or development
            cardiorespiratory depression and hence is the preferred sin-  of nystagmus (rhythmic back-and-forth move-
            gle agent for pain control for any patient at risk of develop-  ment of the eyes)
            ing shock or respiratory distress. Ketamine administration   Analgesia notes:
            may occur via IV, IO, IM, or IN routes.            a.  Casualties may need to be disarmed after being given
          5.  Some situations will require prolonged analgesia or full   OTFC or ketamine.
            dissociation. While it is unreasonable to outline every situ-  b.  Document a mental status exam using the AVPU method
            ation in which this need may occur, responders may utilize   prior to administering opioids or ketamine.
            sedation for cases of severe injury to ensure safety and mis-  c.  For all casualties given opioids or ketamine – monitor
            sion completion or cases where procedural sedation is nec-  airway, breathing, and circulation closely
            essary. The use of sedation requires monitoring with pulse   d.  Directions for administering OTFC:
            oximetry and preferably ETCO .                        •  Recommend taping lozenge-on-a-stick to casualty’s
                                     2
          6.  Tier 4 (paramedic level) responders should rarely need to   finger as an added safety measure OR utilizing a
            administer midazolam with patients experiencing untoward   safety pin and rubber band to attach the lozenge
            effects of ketamine such as dysphoria or emergence phe-  (under tension)  to the patient’s  uniform or plate
            nomena. If the patient appears only partially dissociated,   carrier.
            it is preferrable to administer more ketamine rather than   •  Reassess in 15 minutes
            administering an additional drug. If behavioral disturbances   •  Add second lozenge, in other cheek, as necessary to
            or unpleasant sensations occur and ongoing pain control   control severe pain
            is not needed (for example a procedure is complete, the   •  Monitor for respiratory depression
            CASEVAC has arrived at the next level of care, etc.), then   e.  IV Morphine is an alternative to OTFC if IV access has
            responders may consider midazolam to address these un-  been obtained
            pleasant sensations but should avoid this medication unless   •  5mg IV/IO
            it is clearly needed because of the concern regarding respi-  •  Reassess in 10 minutes.
            ratory depression. Alterations in behavior, mentation, and   •  Repeat dose every 10 minutes as necessary to control
            sensorium may also be due to other causes including hypo-  severe pain.
            tension, hypoxia, hypercarbia, hypo/hyperthermia and head   •  Monitor for respiratory depression.
            injury and responders should treat those underlying causes.  f.  Naloxone (0.4mg IV or IM) should be available when
          6.  Responders should not administer benzodiazepines pro-  using opioid analgesics.
            phylactically, in unmonitored patients, or in casualties who   g.  Both ketamine and OTFC have the potential to worsen
            have received opioids.                                severe TBI. The combat medic, corpsman, or PJ must
                                                                  consider this fact in his or her analgesic decision, but if
          Current Wording in the TCCC Guidelines                  the casualty is able to complain of pain, then the TBI is
                                                                  likely not severe enough to preclude the use of ketamine
          Analgesia
            a.  Analgesia on the battlefield should generally be achieved   or OTFC.
               using one of three options:                     h.  Eye injury does not preclude the use of ketamine. The
                                                                  risk of additional damage to the eye from using ket-
          Option 1                                                amine is low and maximizing the casualty’s chance for
               •  Mild to Moderate Pain                           survival takes precedence if the casualty is in shock or
               •  Casualty is still able to fight                 respiratory distress or at significant risk for either.
                    o TCCC Combat Wound Medication Pack (CWMP)  i.  Ketamine is a useful adjunct to reduce the amount of
                    ■   Tylenol – 650mg bilayer caplet, 2 PO every 8   opioids required to provide effective pain relief. It is safe
                      hours                                       to give ketamine to a casualty who has previously re-
                    ■   Meloxicam – 15mg PO once a day            ceived morphine or OTFC. IV Ketamine should be given
                                                                  over 1 minute.
          Option 2
               •  Moderate to Severe Pain                      j.  If respirations are noted to be reduced after using opi-
               •  Casualty IS NOT in shock or respiratory distress  oids or ketamine, provide ventilatory  support with a
          AND                                                     bag-valve-mask or mouth-to-mask ventilations.
               •  Casualty IS NOT at significant risk of developing ei-  k.  Ondansetron, 4mg Orally Dissolving Tablet (ODT)/IV/
                  ther condition                                  IO/IM, every 8 hours as needed for nausea or vomiting.
                    o Oral transmucosal fentanyl citrate (OTFC) 800 μg  Each 8-hour dose can be repeated once at 15 minutes
                                                                  if nausea and vomiting are not improved. Do not give
                    ■   Place lozenge between the cheek and the gum  more than 8mg in any 8-hour interval. Oral ondan-
                    ■   Do not chew the lozenge

          160  |  JSOM   Volume 22, Edition 2 / Summer 2022
   159   160   161   162   163   164   165   166   167   168   169